These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37627458)

  • 41. The Longitudinal Outcome Of Canine (K9) myxomatous mitral valve disease (LOOK-Mitral registry): Baseline characteristics.
    Franchini A; Borgarelli M; Abbott JA; Menciotti G; Crosara S; Häggström J; Lahmers S; Rosenthal S; Tyrrell W
    J Vet Cardiol; 2021 Aug; 36():32-47. PubMed ID: 34062479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breed-specific values for vertebral heart score (VHS), vertebral left atrial size (VLAS), and radiographic left atrial dimension (RLAD) in pugs without cardiac disease, and their relationship to Brachycephalic Obstructive Airway Syndrome (BOAS).
    Wiegel PS; Mach R; Nolte I; Freise F; Levicar C; Merhof K; Bach JP
    PLoS One; 2022; 17(9):e0274085. PubMed ID: 36054125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of the vertebral heart score in coughing dogs with chronic degenerative mitral valve disease.
    Guglielmini C; Diana A; Pietra M; Di Tommaso M; Cipone M
    J Vet Med Sci; 2009 Jan; 71(1):9-13. PubMed ID: 19194070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vertebral Heart Scale for the Brittany Spaniel: Breed-Specific Range and Its Correlation with Heart Disease Assessed by Clinical and Echocardiographic Findings.
    Kallassy A; Calendrier E; Bouhsina N; Fusellier M
    Vet Sci; 2021 Dec; 8(12):. PubMed ID: 34941827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease.
    Li Q; Freeman LM; Rush JE; Laflamme DP
    Int J Mol Sci; 2015 Jun; 16(6):14098-108. PubMed ID: 26101868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Novel Standardized Method for Aiding to Determine Left Atrial Enlargement on Lateral Thoracic Radiographs in Dogs.
    Szatmári V; Hofman ZMM; van Bijsterveldt NJ; Tellegen AR; Vilaplana Grosso FR
    Animals (Basel); 2023 Jul; 13(13):. PubMed ID: 37443976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of radiographic measurements to diagnose stage B2 preclinical myxomatous mitral valve disease in dogs.
    Stepien RL; Rak MB; Blume LM
    J Am Vet Med Assoc; 2020 May; 256(10):1129-1136. PubMed ID: 32364449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Echocardiographic predictors of survival in dogs with myxomatous mitral valve disease.
    Sargent J; Muzzi R; Mukherjee R; Somarathne S; Schranz K; Stephenson H; Connolly D; Brodbelt D; Fuentes VL
    J Vet Cardiol; 2015 Mar; 17(1):1-12. PubMed ID: 25586168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of an artificial intelligence-based algorithm for predicting the severity of myxomatous mitral valve disease from thoracic radiographs by using two grading systems.
    Valente C; Wodzinski M; Guglielmini C; Poser H; Chiavegato D; Zotti A; Venturini R; Banzato T
    Res Vet Sci; 2024 Oct; 178():105377. PubMed ID: 39137607
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
    Nakamura K; Kawamoto S; Osuga T; Morita T; Sasaki N; Morishita K; Ohta H; Takiguchi M
    J Vet Intern Med; 2017 Mar; 31(2):316-325. PubMed ID: 28145607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The vertebral heart scale on CT is correlated to radiographs in dogs.
    Timperman L; Habing G; Green E
    Vet Radiol Ultrasound; 2021 Sep; 62(5):519-524. PubMed ID: 34148273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolomics Analysis Reveals Deranged Energy Metabolism and Amino Acid Metabolic Reprogramming in Dogs With Myxomatous Mitral Valve Disease.
    Li Q; Larouche-Lebel É; Loughran KA; Huh TP; Suchodolski JS; Oyama MA
    J Am Heart Assoc; 2021 May; 10(9):e018923. PubMed ID: 33890477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biologic variability of cardiac troponin I in healthy dogs and dogs with different stages of myxomatous mitral valve disease using standard and high-sensitivity immunoassays.
    Winter RL; Saunders AB; Gordon SG; Miller MW; Fosgate GT; Suchodolski JS; Steiner JM
    Vet Clin Pathol; 2017 Jun; 46(2):299-307. PubMed ID: 28449360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retrospective evaluation of notched and fragmented QRS complex in dogs with naturally occurring myxomatous mitral valve disease.
    Baisan RA; Turcu CA; Condurachi EI; Vulpe V
    Vet Q; 2021 Dec; 41(1):301-307. PubMed ID: 34643161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of expiratory phase for radiographic detection of left heart enlargement in dogs with mitral regurgitation.
    Chhoey S; Lee SK; Je H; Jung JW; Jang Y; Choi J
    Vet Radiol Ultrasound; 2020 May; 61(3):291-301. PubMed ID: 32173960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of heart rate turbulence in dogs with myxomatous mitral valve disease.
    Dos Santos JP; Lucina SB; da Costa BN; Olaguivel KLC; Tuleski GLR; Sousa MG
    Open Vet J; 2021; 11(4):635-644. PubMed ID: 35070858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The heart to single vertebra ratio: A new objective method for radiographic assessment of cardiac silhouette size in dogs.
    Costanza D; Greco A; Piantedosi D; Bruzzese D; Pasolini MP; Coluccia P; Castiello E; Baptista CS; Meomartino L
    Vet Radiol Ultrasound; 2023 May; 64(3):378-384. PubMed ID: 36480112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sildenafil improves heart rate variability in dogs with asymptomatic myxomatous mitral valve degeneration.
    Pirintr P; Saengklub N; Limprasutr V; Sawangkoon S; Kijtawornrat A
    J Vet Med Sci; 2017 Sep; 79(9):1480-1488. PubMed ID: 28717064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Severity of myxomatous mitral valve disease in dogs may be predicted using neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratio.
    Ku D; Chae Y; Kim C; Koo Y; Lee D; Yun T; Chang D; Kang BT; Yang MP; Kim H
    Am J Vet Res; 2023 Jun; 84(6):. PubMed ID: 37024099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease.
    Ogawa M; Hori Y; Kanno N; Iwasa N; Toyofuku T; Isayama N; Yoshikawa A; Akabane R; Sakatani A; Miyakawa H; Hsu HH; Miyagawa Y; Takemura N
    J Vet Med Sci; 2021 Apr; 83(4):705-715. PubMed ID: 33551383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.